Related Experiment Video

Updated: Aug 16, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas

J A Cohen1, J Geradts

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill 27599-7525, USA.

Human Pathology
|August 1, 1997
PubMed

Insights

Abnormal expression of p16 and retinoblastoma protein (pRB) is common in sarcomas, affecting over half of tumors. This suggests their aberrant expression is a key event in sarcoma development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p16/CDKN2 and pRB proteins are critical regulators of the cell cycle, inhibiting progression at the G1 checkpoint.
  • Loss of p16 or pRB function is implicated in various human cancers.
  • Their role in mesenchymal neoplasia, particularly sarcomas, is less understood.

Purpose of the Study:

  • To investigate the frequency and patterns of aberrant p16 and pRB expression in a cohort of human sarcomas.
  • To determine if p16/pRB abnormalities correlate with histological subtype, grade, or tumor progression.

Main Methods:

  • Immunohistochemistry was employed to assess the expression of p16 and pRB proteins in 59 sarcoma samples.
  • Expression levels were analyzed in relation to histological subtypes and clinicopathological features.

Main Results:

  • Abnormal expression of p16 or pRB was detected in 51% of sarcomas (30 out of 59 cases).
  • Leiomyosarcomas showed the highest rates of abnormality for both proteins.
  • No significant correlation was found between p16/pRB expression and tumor grade or progression.
  • Low-grade spindle cell neoplasms rarely showed p16/pRB abnormalities.

Conclusions:

  • Aberrant p16/pRB expression is a frequent molecular alteration in sarcomagenesis.
  • These tumor suppressor genes are significantly implicated in the development of sarcomas, especially leiomyosarcomas.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...